Literature DB >> 17378753

Evidence that aging and amyloid promote microglial cell senescence.

Barry E Flanary1, Nicole W Sammons, Cuong Nguyen, Douglas Walker, Wolfgang J Streit.   

Abstract

Advanced age and presence of intracerebral amyloid deposits are known to be major risk factors for development of neurodegeneration in Alzheimer's disease (AD), and both have been associated with microglial activation. However, the specific role of activated microglia in AD pathogenesis remains unresolved. Here we report that microglial cells exhibit significant telomere shortening and reduction of telomerase activity with normal aging in rats, and that in humans there is a tendency toward telomere shortening with presence of dementia. Human brains containing high amyloid loads demonstrate a significantly higher degree of microglial dystrophy than nondemented, amyloid-free control subjects. Collectively, these findings show that microglial cell senescence associated with telomere shortening and normal aging is exacerbated by the presence of amyloid. They suggest that degeneration of microglia is a factor in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17378753     DOI: 10.1089/rej.2006.9096

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  105 in total

1.  Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function.

Authors:  Emalick G Njie; Ellen Boelen; Frank R Stassen; Harry W M Steinbusch; David R Borchelt; Wolfgang J Streit
Journal:  Neurobiol Aging       Date:  2010-07-02       Impact factor: 4.673

2.  Protective Effect of Semisynthetic and Natural Flavonoid on Aged Rat Microglia-enriched Cultures.

Authors:  Nataša Mrvová; Martin Škandík; Štefan Bezek; Lucia Račková
Journal:  Neurotox Res       Date:  2019-06-22       Impact factor: 3.911

Review 3.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

4.  Modulation of inflammatory markers by miR-146a during replicative senescence in trabecular meshwork cells.

Authors:  Guorong Li; Coralia Luna; Jianming Qiu; David L Epstein; Pedro Gonzalez
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

Review 5.  Roles of microglia in brain development, tissue maintenance and repair.

Authors:  Mackenzie A Michell-Robinson; Hanane Touil; Luke M Healy; David R Owen; Bryce A Durafourt; Amit Bar-Or; Jack P Antel; Craig S Moore
Journal:  Brain       Date:  2015-03-29       Impact factor: 13.501

6.  Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.

Authors:  B Teter; T Morihara; G P Lim; T Chu; M R Jones; X Zuo; R M Paul; S A Frautschy; G M Cole
Journal:  Neurobiol Dis       Date:  2019-04-02       Impact factor: 5.996

7.  CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Authors:  Erin G Reed-Geaghan; Julie C Savage; Amy G Hise; Gary E Landreth
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

8.  Age-related differences in interferon regulatory factor-4 and -5 signaling in ischemic brains of mice.

Authors:  Shou-Cai Zhao; Chun Wang; Heng Xu; Wen-Qian Wu; Zhao-Hu Chu; Ling-Song Ma; Ying-Dong Zhang; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

9.  Microglia in the aging brain: relevance to neurodegeneration.

Authors:  Xiao-Guang Luo; Jian-Qing Ding; Sheng-Di Chen
Journal:  Mol Neurodegener       Date:  2010-03-24       Impact factor: 14.195

10.  Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.

Authors:  Wolfgang J Streit; Heiko Braak; Qing-Shan Xue; Ingo Bechmann
Journal:  Acta Neuropathol       Date:  2009-06-10       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.